ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Children with Down syndrome are up to 150 times more likely to develop acute myeloid leukemia before age 5 and yet very ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

I was diagnosed with acute myeloid leukemia, and the prognosis was not good. I was given just a few months to live. The only ...

His mother, Patricia, is a former Southeastern Conference Associate Commissioner as well. Unfortunately, there is no cure for ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

AGOURA HILLS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at SITC 2024. Dr. Cynthia Lee, VP of R&D will be presenting Sapu Bio ...

Patients with myelodysplastic syndromes (MDS) report more frequent symptoms than their physicians, according to a new report.

A Valley woman with leukemia hopes to raise awareness about how stem cell donors are needed for transplants that can treat ...

The FDA has granted accelerated approval to asciminib as a first-line treatment for adults newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia, a rare type of blood cancer.

PP-007 is a unique combination of a carbon monoxide releasing molecule and an oxygen transfer agent. The Food and Drug Administration (FDA) has granted Fast Track designation to PP-007 (PEGylated ...